4.2 Article

Th17 and regulatory T cells: implications for AIDS pathogenesis

期刊

CURRENT OPINION IN HIV AND AIDS
卷 5, 期 2, 页码 151-157

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/COH.0b013e328335c0c1

关键词

HIV; indoleamine 2,3-dioxygenase; regulatory T cells; Th17 cells

资金

  1. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK083334, T32DK007762, K24DK060617] Funding Source: NIH RePORTER
  2. NIDDK NIH HHS [T32 DK007762, K08 DK083334, K08 DK083334-01A1, K24 DK060617] Funding Source: Medline

向作者/读者索取更多资源

Purpose of review The present review discusses recent reports showing that reciprocal changes in T helper interleukin-17-secreting CD4(+) Th17 cells and CD4(+)CD25(high)FoxP3(+) regulatory T cells (Tregs) may play a role in the progressive disease caused by the HIV and by simian immunodeficiency virus. Recent findings Studies in nonhuman primate models of lentiviral infection and in HIV-infected human individuals have shown that pathogenic infection is associated with loss of Th17 cells and an increase in the frequency of Tregs. Because interleukin-17 serves to maintain the integrity of the mucosal barrier, loss of Th17 cells may permit the increase in microbial translocation across the gastrointestinal mucosa that is observed in pathogenic lentiviral disease. It remains unclear, however, whether Th17 cells are preferentially infected or if, instead, their loss is induced by bystander effects of lentiviral infection, for example, the induction of indoleamine 2,3-dioxygenase. Summary Progressive lentiviral disease is associated with preferential depletion of Th17 cells and loss of Th17/Treg balance. Further analysis of such changes in the composition of subset CD4(+) T helper and Tregs may shed new light on the immunopathology of HIV disease and suggest new strategies for therapeutic and preventive interventions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination

Slim Fourati, Razvan Cristescu, Andrey Loboda, Aarthi Talla, Ali Filali, Radha Railkar, Andrea K. Schaeffer, David Favre, Dominic Gagnon, Yoav Peretz, I-Ming Wang, Chan R. Beals, Danilo R. Casimiro, Leonidas N. Carayannopoulos, Rafick-Pierre Sekaly

NATURE COMMUNICATIONS (2016)

Article Oncology

Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer

Elizabeth Scheid, Pierre Major, Alain Bergeron, Olivera J. Finn, Russell D. Salter, Robin Eady, Bader Yassine-Diab, David Favre, Yoav Peretz, Claire Landry, Sebastien Hotte, Som D. Mukherjee, Gregory A. Dekaban, Corby Fink, Paula J. Foster, Jeffery Gaudet, Jean Gariepy, Rafick-Pierre Sekaly, Louis Lacombe, Yves Fradet, Ronan Foley

CANCER IMMUNOLOGY RESEARCH (2016)

Review Neurosciences

Tunneling Nanotubes and Gap Junctions-Their Role in Long-Range Intercellular Communication during Development, Health, and Disease Conditions

Jennifer Ariazi, Andrew Benowitz, Vern De Biasi, Monique L. Den Boer, Stephanie Cherqui, Haifeng Cui, Nathalie Douillet, Eliseo A. Eugenin, David Favre, Spencer Goodman, Karine Gousset, Dorit Hanein, David I. Israel, Shunsuke Kimura, Robert B. Kirkpatrick, Nastaran Kuhn, Claire Jeong, Emil Lou, Robbie Mailliard, Stephen Maio, George Okafo, Matthias Osswald, Jennifer Pasquier, Roel Polak, Gabriele Pradel, Bob de Rooij, Peter Schaeffer, Vytenis A. Skeberdis, Ian F. Smith, Ahmad Tanveer, Niels Volkmann, Zhenhua Wu, Chiara Zurzolo

FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)

Article Hematology

Correlating cellular and molecular signatures of mucosal immunity that distinguish HIV controllers from noncontrollers

P'ng Loke, David Favre, Peter W. Hunt, Jacqueline M. Leung, Bittoo Kanwar, Jeffrey N. Martin, Steven G. Deeks, Joseph M. McCune

Article Hematology

HIV disease progression correlates with the generation of dysfunctional naive CD8low T cells

David Favre, Cheryl A. Stoddart, Brinda Emu, Rebecca Hoh, Jeffrey N. Martin, Frederick M. Hecht, Steven G. Deeks, Joseph M. McCune

Article Immunology

Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens

Nathalie Landry, Stephane Pillet, David Favre, Jean-Francois Poulin, Sonia Trepanier, Bader Yassine-Diab, Brian J. Ward

CLINICAL IMMUNOLOGY (2014)

Meeting Abstract Cell & Tissue Engineering

VACCINATION WITH AUTOLOGOUS DENDRITIC CELLS PULSED WITH A MUC1 GLYCOPEPTIDE: A PHASE I/II STUDY IN CASTRATE RESISTANT NON-METASTATIC PROSTATE CANCER PATIENTS

E. Scheid, A. Bergeron, G. A. Dekaban, D. Favre, R. Eady, P. O'Hoski, P. Major, R. Foley

CYTOTHERAPY (2013)

Article Cell Biology

Tryptophan Catabolism by Indoleamine 2,3-Dioxygenase 1 Alters the Balance of TH17 to Regulatory T Cells in HIV Disease

David Favre, Jeff Mold, Peter W. Hunt, Bittoo Kanwar, P'ng Loke, Lillian Seu, Jason D. Barbour, Margaret M. Lowe, Anura Jayawardene, Francesca Aweeka, Yong Huang, Daniel C. Douek, Jason M. Brenchley, Jeffrey N. Martin, Frederick M. Hecht, Steven G. Deeks, Joseph M. McCune

SCIENCE TRANSLATIONAL MEDICINE (2010)

Article Chemistry, Medicinal

DNA-Encoded Library Technology-Based Discovery, Lead Optimization, and Prodrug Strategy toward Structurally Unique Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors

Wieslaw M. Kazmierski, Bing Xia, John Miller, Martha De la Rosa, David Favre, Richard M. Dunham, Yoshiaki Washio, Zhengrong Zhu, Feng Wang, Makda Mebrahtu, Hongfeng Deng, Jonathan Basilla, Liping Wang, Ghotas Evindar, Lijun Fan, Alison Olszewski, Ninad Prabhu, Christopher Davie, Jeffrey A. Messer, Vicente Samano

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Multidisciplinary Sciences

Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo

Christopher C. Nixon, Maud Mavigner, Gavin C. Sampey, Alyssa D. Brooks, Rae Ann Spagnuolo, David M. Irlbeck, Cameron Mattingly, Phong T. Ho, Nils Schoof, Corinne G. Cammon, Greg K. Tharp, Matthew Kanke, Zhang Wang, Rachel A. Cleary, Amit A. Upadhyay, Chandrav De, Saintedym R. Wills, Shane D. Falcinelli, Cristin Galardi, Hasse Walum, Nathaniel J. Schramm, Jennifer Deutsch, Jeffrey D. Lifson, Christine M. Fennessey, Brandon F. Keele, Sherrie Jean, Sean Maguire, Baolin Liao, Edward P. Browne, Robert G. Ferris, Jessica H. Brehm, David Favre, Thomas H. Vanderford, Steven E. Bosinger, Corbin D. Jones, Jean-Pierre Routy, Nancie M. Archin, David M. Margolis, Angela Wahl, Richard M. Dunham, Guido Silvestri, Ann Chahroudi, J. Victor Garcia

NATURE (2020)

Article Biochemistry & Molecular Biology

CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption

Justin Harper, Shari Gordon, Chi Ngai Chan, Hong Wang, Emily Lindemuth, Cristin Galardi, Shane D. Falcinelli, Samuel L. M. Raines, Jenna L. Read, Kevin Nguyen, Colleen S. McGary, Michael Nekorchuk, Kathleen Busman-Sahay, James Schawalder, Colin King, Maria Pino, Luca Micci, Barbara Cervasi, Sherrie Jean, Andrew Sanderson, Brian Johns, A. Alicia Koblansky, Heather Amrine-Madsen, Jeffrey Lifson, David M. Margolis, Guido Silvestri, Katharine J. Bar, David Favre, Jacob D. Estes, Mirko Paiardini

NATURE MEDICINE (2020)

Article Biochemistry & Molecular Biology

Characterization of Apo-Form Selective Inhibition of Indoleamine 2,3-Dioxygenase

Rodrigo F. Ortiz-Meoz, Liping Wang, Rosalie Matico, Anna Rutkowska-Klute, Martha De la Rosa, Sabrina Bedard, Robert Midgett, Katrin Strohmer, Douglas Thomson, Cunyu Zhang, Makda Mebrahtu, Jeffrey Guss, Rachel Totoritis, Thomas Consler, Nino Campobasso, David Taylor, Tia Lewis, Kurt Weaver, Marcel Muelbaier, John Seal, Richard Dunham, Wieslaw Kazmierski, David Favre, Giovanna Bergamini, Lisa Shewchuk, Alan Rendina, Guofeng Zhang

Summary: IDO1 is an immunoregulatory enzyme of interest for its potential therapeutic implications in cancer treatment. IDO1 inhibitors can act by competing with heme for binding or by coordinating their binding with the iron atom of IDO1 heme cofactor. Each mechanism may offer unique advantages in terms of specificity and duration of inhibition.

CHEMBIOCHEM (2021)

Meeting Abstract Immunology

Activation of latent HIV and SIV RNA transcription in vitro and in vivo in ART suppressed SIV-infected rhesus macaques by the Ingenol-based protein kinase C agonist, GSK445A

A. Okoye, R. Fromentin, J. Brehm, A. Maxwell, M. Vaidya, M. Pardons, V. Tai, J. Tang, J. Smedly, M. Axthelm, J. Lifson, L. Picker, L. Trautmann, D. Favre, N. Chomont

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2018)

Article Immunology

Wake me up before you go: a strategy to reduce the latent HIV reservoir

Nicolas Chomont, Afam A. Okoye, David Favre, Lydie Trautmann

暂无数据